VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+10.73%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$188M
AUM Growth
+$30.7M
(+19%)
Cap. Flow
+$19.9M
Cap. Flow
% of AUM
10.59%
Top 10 Holdings %
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73
Top Buys
| 1 |
Palantir
PLTR
|
$1.01M |
| 2 |
BlackRock TCP Capital
TCPC
|
$1M |
| 3 |
Host Hotels & Resorts
HST
|
$993K |
| 4 |
DFS
Discover Financial Services
DFS
|
$989K |
| 5 |
Public Storage
PSA
|
$931K |
Top Sells
| 1 |
Burlington
BURL
|
$962K |
| 2 |
Prologis
PLD
|
$773K |
| 3 |
Booking.com
BKNG
|
$734K |
| 4 |
Eaton
ETN
|
$720K |
| 5 |
TE Connectivity
TEL
|
$708K |
Sector Composition
| 1 | Healthcare | 21.52% |
| 2 | Financials | 20.16% |
| 3 | Technology | 16.46% |
| 4 | Industrials | 8.76% |
| 5 | Energy | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Merus
MRUS
$5.1B
| $154K | 0.08% |
3,431
-231
| -6% | -$10.4K |
|
327
Companhia Siderúrgica Nacional
SID
$1.99B
| $152K | 0.08% |
+48,556
| New | +$152K |
|
328
New Fortress Energy
NFE
$672M
| $151K | 0.08% |
+4,949
| New | +$151K |
|
|
BLUE
329
DELISTED
bluebird bio
BLUE
| $148K | 0.08% |
5,773
+831
| +17% | +$21.3K |
|
330
B2Gold
BTG
$5.52B
| $146K | 0.08% |
55,862
-9,315
| -14% | -$24.3K |
|
|
BCYC
331
Bicycle Therapeutics
BCYC
$496M
| $144K | 0.08% |
5,774
-398
| -6% | -$9.91K |
|
332
Vale
VALE
$44.4B
| $143K | 0.08% |
+11,737
| New | +$143K |
|
333
Allogene Therapeutics
ALLO
$255M
| $143K | 0.08% |
31,967
-2,196
| -6% | -$9.82K |
|
334
Nurix Therapeutics
NRIX
$758M
| $142K | 0.08% |
9,693
-663
| -6% | -$9.75K |
|
335
MacroGenics
MGNX
$126M
| $137K | 0.07% |
9,309
-635
| -6% | -$9.35K |
|
336
Kymera Therapeutics
KYMR
$3.11B
| $137K | 0.07% |
3,407
-231
| -6% | -$9.29K |
|
337
Summit Therapeutics
SMMT
$19.3B
| $136K | 0.07% |
32,815
-2,254
| -6% | -$9.33K |
|
338
Mineralys Therapeutics
MLYS
$2.7B
| $136K | 0.07% |
10,501
-721
| -6% | -$9.31K |
|
339
Krystal Biotech
KRYS
$4.35B
| $132K | 0.07% |
744
-52
| -7% | -$9.25K |
|
340
Oric Pharmaceuticals
ORIC
$1.06B
| $130K | 0.07% |
9,437
-648
| -6% | -$8.91K |
|
341
Geron
GERN
$893M
| $129K | 0.07% |
39,205
-2,687
| -6% | -$8.87K |
|
|
IGMS
342
DELISTED
IGM Biosciences
IGMS
| $129K | 0.07% |
13,332
-911
| -6% | -$8.79K |
|
343
Biohaven
BHVN
$1.68B
| $126K | 0.07% |
2,303
-156
| -6% | -$8.53K |
|
344
BlackRock 2037 Municipal Target Term Trust
BMN
$151M
| $123K | 0.07% |
5,083
+1,813
| +55% | +$43.7K |
|
345
Protagonist Therapeutics
PTGX
$3.77B
| $121K | 0.06% |
4,175
-282
| -6% | -$8.16K |
|
346
Arcellx
ACLX
$4.03B
| $117K | 0.06% |
1,688
-117
| -6% | -$8.14K |
|
347
Cogent Biosciences
COGT
$1.82B
| $117K | 0.06% |
17,467
-1,199
| -6% | -$8.06K |
|
348
Crinetics Pharmaceuticals
CRNX
$3.35B
| $116K | 0.06% |
2,479
-175
| -7% | -$8.19K |
|
349
ImmunityBio
IBRX
$2.27B
| $114K | 0.06% |
21,290
-1,457
| -6% | -$7.82K |
|
350
IDEAYA Biosciences
IDYA
$2.38B
| $111K | 0.06% |
2,535
-170
| -6% | -$7.46K |
|